|
The French-American Chamber of Commerce of San
Francisco
cordially invites you to join us for a:
Life Science Breakfast - IP and biotech, is
there a road map?
Intellectual Property (IP) is essential to
the success of any life biotech company and a primary concern to
investors, just as technology, market and management.
The level of complexity of the issues, the costs, the challenges faced
among Offices of Technology Transfers (OTT) make IP a
major headache
issue for the whole industry. To add to the complexity of the current
regulations, the United States Patent Office, (USPTO), is about to
reform their procedures in a fashion that seems to engender
controversy, and apparently pleases no one, to say the least.
Our speakers will share their experience on the issues and hopefully
some advices that will help us better understand how IP affects the
industry.
Click here to get the
press review about this
subject.
Click here to get the
presentation of Roger Werne.
Click here to get the
presentation of
Tod Stoltz.
Thursday,
May 11th, 2006
7:30 am - 9:30 am
At
Swissnex
730 Montgomery Street
San Francisco
Breakfast will be served
Swissnex connects the dots in science, education,
art and innovation,
between Switzerland and Western North America
Special thanks
to our sponsor:
Croissant courtesy of Brioche Bakery
  
Thanks for the support of:
and to our communication sponsor:
__________________________________________
MODERATOR
John E. Hamer,
Entrepreneur-in-Residence, Burrill & Company.
 John joined Burrill
& Company in November 2003 as Entrepreneur-In-Residence. John helped to build
Paradigm Genetics Inc. a publicly-traded biotechnology company in Research
Triangle Park, North Carolina from its beginning in 1998 serving in various
capacities as Director of Microbial Research, Vice President of Research, Chief
Scientific Officer, Vice President for Business Development and Interim
President and CEO.
John received his Ph.D. in Microbiology from the University of California, Davis
in 1987 and was a visiting scientist at Dupont's Central Research and
Development from 1987 to 1989. He served on the faculty of Purdue University
where he held the positions of Assistant Professor ('89-'90), Associate
Professor ('92-'98), Professor ('98-'00) and Adjunct Professor of Microbiology
and Immunology at Indiana University/Purdue University Medical School.
He currently holds an honorary position as Adjunct Professor of Biological
Sciences. John has received numerous grants and awards of distinction throughout
his career including a David and Lucille Packard Fellowship (1990-1995) and the
National Science Foundation Presidential Faculty Fellowship (1993-1998). He has
served on numerous scientific review and biotechnology advisory boards including
those at the National Institutes of Health, the National Science Foundation,
Purdue Alumni Science Advisory Board and North Carolina Genomic and
Bioinformatics Consortium. Mr. Hamer serves on the Boards of Directors of
AgraQuest (observer), Chlorogen, CropDesign (observer) and E-Markets. John
recently co-founded and serves as CEO/President of Arete Therapeutics Inc., a
cardiovascular drug development company.
__________________________________________
SPEAKERS
Catherine Maresh,
Senior Patent Counsel, Medtronic
 As Senior
Patent Counsel of Medtronic Vascular, Inc. Catherine handles patent and other
intellectual property matters, including worldwide IP and litigation strategy.
In addition to working with employees in the U.S., she works with the employees
located at Medtronic's Galway, Ireland facility. Medtronic's Galway facility is
one of two industrial partners in the Regenerative Medicine Institute (REMEDI)
based at the National University of Ireland-Galway. REMEDI is a biomedical
research centre focusing on gene therapy and stem cell research with the aim of
regeneration and repair of tissues.
Prior to joining Medtronic in 1999, Catherine practiced IP litigation and
prosecution at the law firm of Haugen & Nikolai, P.A. for eight years in
Minneapolis, Minnesota. Catherine is registered to practice in Minnesota,
California, and before the U.S. Patent Office.
Medtronic is the world leader in medical technology providing lifelong solutions
for people with chronic disease. Medtronic’s vascular division focuses on
treating coronary vascular, peripheral vascular, endovascular, and neurovascular
disease. Medtronic Vascular offers a full complement of products for
interventional procedures, including stents, drug-coated stents, stent grafts,
balloon angioplasty catheters, guiding catheters, guidewires, and diagnostic
catheters and accessories.
Tod Stoltz, Manager
Technology Business Development, UC Davis Health System, Office of Research
Technology and Industry Alliances
 Graduated in 1993 with a degree in genetics from UCDavis.
Began working for Ray Rodriguez in the Department of Molecular and Cellular Biology to complete the development of a system for production of pharmaceutical proteins in plants.
In 1994, helped start Applied Phytologics, Inc, in Sacramento to exploit this new technology, where he worked for 9 years, doing laboratory work, establishing the companies field trial program, and leading efforts to obtain FDA, and USDA approval of their products and their production method.
Left API in 2002 to attend the UCDavis Graduate School of Management.
After graduating in March of 2004, started a new unit at the UCDavis Medical Center called Technology Business Development to help commercialize new medical technology being developed at UCDavis.
Roger Werne,
Senior Advisor for Industrial Partnership, Lawrence Livermore National
Laboratory.
 Dr. Werne has broad experience in the commercialization of technology developed within the Lawrence Livermore National Laboratory. In the late eighties he started and led the LLNL Industrial Partnering program while he was Associate Director for Engineering. Engineering at LLNL was an organization of approximately 2,500 people that supported all Laboratory Programs including nuclear weapons, nonproliferation, advanced conventional defense, inertial confinement and magnetic fusion, energy research, and biotechnology. In 1995 he co-founded ITI Medical Technologies, a medical device start-up company focused on the field of Magnetic Resonance Image(MRI) guided surgery, a new minimally invasive surgical paradigm. In late 1999 he rejoined the Laboratory as Chief Engineer for the NAI/Homeland Security Directorate having the mission of countering the proliferation and use of weapons of mass destruction(WMD) against the United States.
Dr. Werne received his Ph.D. in Structures and Solid Mechanics from the University of California at Berkeley. Dr. Werne is also a pole vaulter in Masters Track & Field ranked in the top five in the U.S. in 2005 in his age group and a part time Assistant Track and Field Coach at a local high school.
__________________________________________
REGISTRATION
Registration price valid until 5-days
Prior to the
event
date
Cancellations must be made 5-days prior to the event date
Any cancellation within a 5-day period of the scheduled date will
not be refunded
Name of guest will be kept at
the door
$20 for members $25 for
non-members
$30 at the door
PRE
REGISTRATION IS NOW CLOSED.
Or please mail or fax the reservation Card below
Reservation Card - 05/11 Life Science Breakfast
Please reserve ___ seat (s) at $20 per person (for Members).
Please reserve ___ seat (s) at $25 per person (for Non Members).
Name________________________________________________________________
Company______________________________________________________________
Address_______________________________________________________________
Email address______________________________________________ for
confirmation
Phone number __________________________________________________________
Visa/MC Number_________________________________________________________
Expires________Signature_________________________________________________
Please make checks payable to FACCSF
Please, fax this coupon to
French-American Chamber of Commerce
703 Market Street, Suite 450, San Francisco, CA
94103
Tel: 415 442 4717 / Fax 415 442 4621
|
